Silvia Arrigucci
Overview
Explore the profile of Silvia Arrigucci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Isacchi B, Arrigucci S, la Marca G, Bergonzi M, Vannucchi M, Novelli A, et al.
J Liposome Res
. 2010 Dec;
21(3):237-44.
PMID: 21158702
Artemisinin (qinghaosu), a unique endoperoxide sesquiterpene lactone isolated from Artemisia annua L., is a very active antimalarial drug, including severe and cerebral malaria. However, its therapeutical efficacy is limited due...
2.
Mazzei T, Novelli A, Arrigucci S
Infez Med
. 2010 Apr;
17 Suppl 4:37-57.
PMID: 20428019
The pharmacodynamic and pharmacokinetic characteristics of antimicrobial agents are the two fundamental pharmacological components which provide a rational for the choice of therapy for skin and skin structure infections, and...
3.
Mariottini C, Scartabelli T, Bongers G, Arrigucci S, Nosi D, Leurs R, et al.
J Neurochem
. 2009 Jun;
110(5):1469-78.
PMID: 19549072
Stimulation of histamine H(3) receptors (H(3)R) activates G(i/o)-proteins that inhibit adenylyl cyclase and triggers MAPK and phospholipase A(2). In a previous study, we showed that H(3)R-mediated phosphorylation of Akt at...
4.
Arrigucci S, Garcea A, Fallani S, Cassetta M, Canonico G, Tonelli F, et al.
Int J Antimicrob Agents
. 2008 Dec;
33(4):371-3.
PMID: 19097758
Ertapenem, a novel carbapenem, is approved for the treatment of mild to severe intra-abdominal infections (IAIs), although its in vivo concentrations in peritoneal fluid are unknown. The purpose of this...
5.
Adembri C, Fallani S, Cassetta M, Arrigucci S, Ottaviano A, Pecile P, et al.
Int J Antimicrob Agents
. 2007 Dec;
31(2):122-9.
PMID: 18055183
Pharmacokinetics and pharmacodynamics are significantly altered in critically ill septic patients and the risk of prolonged periods with concentrations below the minimum inhibitory concentration (MIC) and of low area under...
6.
Mazzei T, Cassetta M, Fallani S, Arrigucci S, Novelli A
Int J Antimicrob Agents
. 2006 Jul;
28 Suppl 1:S35-41.
PMID: 16829051
Uncomplicated urinary tract infections (UTI) are treated with beta-lactams, co-trimoxazole, quinolones and fosfomycin tromethamine. Due to increasing resistance of causative pathogens, antibiotics should be used by considering their pharmacodynamic and...
7.
Dolara P, Arrigucci S, Cassetta M, Fallani S, Novelli A
Int J Antimicrob Agents
. 2005 Sep;
26(4):338-40.
PMID: 16139991
No abstract available.